SAVELLA Trademark

Trademark Overview

On Thursday, June 21, 2007, a trademark application was filed for SAVELLA with the United States Patent and Trademark Office. The USPTO has given the SAVELLA trademark a serial number of 77211766. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 28, 2020. This trademark is owned by Forest Laboratories, Inc.. The SAVELLA trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of fibromylagia [ and neuropathic pain disorders ]
savella

General Information

Serial Number77211766
Word MarkSAVELLA
Filing DateThursday, June 21, 2007
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 28, 2020
Registration Number3658661
Registration DateTuesday, July 21, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 4, 2007

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of fibromylagia [ and neuropathic pain disorders ]

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 28, 2020
Primary Code005
First Use Anywhere DateFriday, April 24, 2009
First Use In Commerce DateFriday, April 24, 2009

Trademark Owner History

Party NameALLERGAN SALES, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressIRVINE, CA 92612
Party NameForest Laboratories, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10022
Party NameForest Laboratories, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10022
Party NameForest Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10022

Trademark Events

Event DateEvent Description
Friday, February 28, 2020CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Wednesday, August 15, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, July 21, 2018COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, August 6, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, August 6, 2014REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, August 6, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 21, 2014TEAS SECTION 8 & 15 RECEIVED
Tuesday, January 8, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 8, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 21, 2009REGISTERED-PRINCIPAL REGISTER
Friday, June 12, 2009LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, June 8, 2009ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 18, 2009STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 29, 2009USE AMENDMENT FILED
Monday, May 18, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 29, 2009TEAS STATEMENT OF USE RECEIVED
Friday, February 20, 2009EXTENSION 2 GRANTED
Friday, February 20, 2009EXTENSION 2 FILED
Friday, February 20, 2009TEAS EXTENSION RECEIVED
Thursday, July 31, 2008EXTENSION 1 GRANTED
Thursday, July 31, 2008EXTENSION 1 FILED
Thursday, July 31, 2008TEAS EXTENSION RECEIVED
Tuesday, February 26, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 4, 2007PUBLISHED FOR OPPOSITION
Wednesday, November 14, 2007NOTICE OF PUBLICATION
Monday, October 29, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 29, 2007ASSIGNED TO LIE
Thursday, September 27, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 22, 2007ASSIGNED TO EXAMINER
Monday, June 25, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

savella pain disorders neuropathic fibromylagia preparations treatment pharmaceutical